9 September 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on four medicines.

Dabrafenib (Finlee) used in combination with another medicine, trametinib (Spexotras) was accepted for treating children aged one year and older with a type of brain tumour called a glioma.

Read SMC press release